📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

PPLPHARMAPharmaceuticals

Piramal Pharma Ltd — Financial Ratios & Key Metrics

₹136.54

+1.77%

P/E RatioN/AxIndustry: 31.77x

ROE1.11%Return on equity

ROCE6.45%Return on capital

Debt/Equity0.60Low debt

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.08%

Market Cap

₹24.56K (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

15.15%

📉

Price Returns

1 Month

-7.39%

3 Months

-0.99%

6 Months

-10.23%

1 Year

-31.21%

52W Low

₹132

Current

₹137

52W High

₹241

4% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹155

▼ Price below SMA 50 — Bearish

SMA 200

₹183

▼ Long-term downtrend

Volume Signal

261% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Piramal Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.